POLDIP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.040200E-01
Normal-vs-Stage2
7.680200E-01
Normal-vs-Stage3
5.736800E-01
Normal-vs-Stage4
5.487400E-01
Stage1-vs-Stage2
4.543400E-01
Stage1-vs-Stage3
2.119400E-01
Stage1-vs-Stage4
2.003600E-01
Stage2-vs-Stage3
1.911170E-01
Stage2-vs-Stage4
3.492200E-01
Stage3-vs-Stage4
7.767600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.124600E-01
Normal-vs-AfricanAmerican
4.476200E-01
Normal-vs-Asian
5.205400E-01
Caucasian-vs-AfricanAmerican
1.885160E-01
Caucasian-vs-Asian
6.437800E-01
AfricanAmerican-vs-Asian
5.068800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.879800E-01
Normal-vs-Female
6.428200E-01
Male-vs-Female
1.604560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.082200E-01
Normal-vs-Age(41-60Yrs)
5.251400E-01
Normal-vs-Age(61-80Yrs)
9.711000E-01
Normal-vs-Age(81-100Yrs)
2.823800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.224000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.478800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.336200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.631500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.204800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.293360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.883400E-01
Normal-vs-Daily Drinker
8.314800E-01
Normal-vs-Weekly Drinker
5.557600E-01
Normal-vs-Occasional Drinker
4.701800E-01
Normal-vs-Social Drinker
3.870600E-01
Non Drinker-vs-Daily Drinker
1.257440E-01
Non Drinker-vs-Weekly Drinker
4.293900E-02
Non Drinker-vs-Occasional Drinker
1.252310E-02
Non Drinker-vs-Social Drinker
6.604000E-03
Daily Drinker-vs-Weekly Drinker
6.703000E-01
Daily Drinker-vs-Occasional Drinker
4.130600E-01
Daily Drinker-vs-Social Drinker
2.455600E-01
Weekly Drinker-vs-Occasional Drinker
6.833200E-01
Weekly Drinker-vs-Social Drinker
4.141000E-01
Occasional Drinker-vs-Social Drinker
6.454800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.604600E-01
Normal-vs-Grade 2
8.956000E-01
Normal-vs-Grade 3
8.559000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.962600E-01
Grade 1-vs-Grade 3
9.529800E-01
Grade 1-vs-Grade 4
8.604600E-01
Grade 2-vs-Grade 3
3.599200E-01
Grade 2-vs-Grade 4
8.956000E-01
Grade 3-vs-Grade 4
8.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.679200E-01
Normal-vs-NonDiabetic
5.631400E-01
Diabetic-vs-NonDiabetic
1.923990E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.396200E-01
Normal-vs-NoPancreatitis
8.851800E-01
Pancreatitis-vs-NoPancreatitis
3.439800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.412800E-01
Normal-vs-N1
7.825800E-01
N0-vs-N1
9.663600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.325800E-01
Normal-vs-TP53-NonMutant
8.003000E-01
TP53-Mutant-vs-TP53-NonMutant
3.876700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
